Associated Papers
Neurological symptoms in adults with Gaucher disease: a systematic review.
Imbalzano G et al.
Journal of Neurology, 2024
38771384 (PubMed )
Supplement: 415_2024_12439_MOESM3_ESM.docx
Long-term velaglucerase alfa treatment in children with Gaucher disease type 1 naïve to enzyme replacement therapy or previously treated with imiglucerase.
Smith L et al.
Molecular Genetics and Metabolism, 2016
Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies.
Barkhuizen M et al.
Neurochemistry International, 2016
Variants associated with Gaucher disease in multiple system atrophy.
Mitsui J et al.
Annals of Clinical and Translational Neurology, 2015
Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3.
Goker-Alpan O et al.
The Journal of Pediatrics, 2003
Analysis of the glucocerebrosidase gene and mutation profile in 144 Italian gaucher patients.
Filocamo M et al.
Human Mutation, 2002
Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.
Choy FY et al.
Blood Cells, Molecules & Diseases, 0
[Distribution of mutations of acid beta-D-glucosidase gene (GBA) among 68 Russian patients with Gaucher's disease].
Bukina TM et al.
Biomeditsinskaia Khimiia, 0
Select a paper to view details